Providers Coverage Costs Reference

51/51 states verified · 25/25 providers audited

Insurance plan

Does Aetna cover GLP-1s for weight loss?

Aetna states it plainly: "Many Aetna plan benefit descriptions specifically exclude services and supplies for or related to treatment of obesity or for diet and weight control. Under these plans, claims for weight reduction medications... will be denied based on that exclusion." So the first thing to read is your own plan document, not Aetna’s criteria.

By John Weeks Checked against the primary source August 25, 2026
Your employer decides, not Aetna. On most commercial plans, whether weight-loss medication is covered at all is chosen by whoever buys the plan. The criteria below apply only once that choice has been made, so the first document to read is your own plan's benefit summary.
What Aetna covers for weight loss, and the criteria that apply.
Medication Position What it asks for
Wegovy Prior authorization Where the plan covers it at all: 18 or over, BMI of 30 or over, or 27 or over with a weight-related condition. Then the hardest requirement any payer on this page sets: you must already have taken part in a weight management program, with follow-up, for at least six months before starting the drug.
Zepbound not checked Governed by its own pharmacy bulletin, which nobody here has opened. We are not going to assume it matches the Wegovy one.

What it takes to keep the coverage

Continuation asks that you have titrated to a stable maintenance dose and that your BMI has fallen from baseline, or that you have kept the reduction you already made. Aetna cites the Endocrine Society guideline behind it, which is the source of the 5% test the other payers use: below 5% at three months, the guideline recommends stopping.

Worth knowing

Aetna is owned by CVS Health, so the CVS Caremark formulary above often sits behind an Aetna plan. They are two different decisions: the formulary says which drug is preferred, the benefit design says whether weight-loss drugs are covered at all.

Asking about one medicine instead

If the answer is no. Around 45% of initial prior authorizations for these drugs are refused, and 35 to 45% of first-level appeals are overturned. A refusal is not the end of the process, and the cash-pay routes are priced on this site alongside it.

Sources

Every claim above is checked against the primary text, and the date is the day we last opened it.

2 cited records
  1. 1
    Aetna Clinical Policy Bulletin 0039: Weight Reduction Programs and Devices

    Aetna Primary text read and checked Checked August 25, 2026

  2. 2
    Aetna Pharmacy Clinical Policy Bulletin: Wegovy PA with Limit (4774-C)

    Aetna Non-Medicare Prescription Drug Plan Primary text read and checked Checked August 25, 2026